Chenglong Li Selected Research

Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)

1/2022	Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.
11/2020	Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.
1/2018	Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.
3/2014	Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chenglong Li Research Topics

Disease

88	Neoplasms (Cancer) 03/2022 - 05/2003
14	Inflammation (Inflammations) 01/2022 - 08/2010
10	Neoplasm Metastasis (Metastasis) 08/2021 - 03/2011
10	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2011
9	Breast Neoplasms (Breast Cancer) 05/2020 - 04/2009
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2006
8	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 08/2010
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2009
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2009
7	Carcinogenesis 01/2021 - 07/2009
6	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2010
6	Leukemia 01/2017 - 02/2006
5	Hypoxia (Hypoxemia) 01/2022 - 01/2018
5	Medulloblastoma 01/2021 - 02/2015
5	Liver Neoplasms (Liver Cancer) 08/2017 - 08/2010
5	Rhabdomyosarcoma 01/2017 - 01/2011
4	Hemorrhage 12/2022 - 01/2020
4	Glioma (Gliomas) 03/2022 - 02/2013
4	Cardiogenic Shock 01/2022 - 11/2019
4	Fibrosis (Cirrhosis) 01/2021 - 01/2021
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 01/2017
4	Acute Lung Injury 06/2019 - 10/2016
3	Necrosis 01/2022 - 07/2007
3	Hematoma 01/2022 - 01/2020
3	Atherosclerosis 02/2021 - 05/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 05/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 12/2011
3	Acute Kidney Injury (Acute Renal Failure) 11/2018 - 09/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2016 - 01/2013
3	Osteosarcoma (Osteogenic Sarcoma) 06/2012 - 03/2011
2	Cognitive Dysfunction 09/2022 - 01/2020
2	Disease Progression 01/2022 - 11/2020
2	Adenocarcinoma 01/2022 - 05/2020
2	Sepsis (Septicemia) 10/2021 - 02/2013
2	Osteoporosis 02/2021 - 01/2017
2	Hypertrophy 01/2021 - 01/2021
2	Thrombosis (Thrombus) 12/2020 - 02/2018
2	Dysbiosis 10/2020 - 01/2019
2	Triple Negative Breast Neoplasms 05/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 04/2020 - 03/2015
2	Abdominal Aortic Aneurysm 01/2020 - 01/2018
2	Heart Diseases (Heart Disease) 01/2020 - 10/2012
2	Rectal Neoplasms (Rectal Cancer) 12/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

26	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 07/2009
25	Interleukin-6 (Interleukin 6)IBA 02/2021 - 01/2010
14	CurcuminIBA 06/2020 - 02/2009
12	Pharmaceutical PreparationsIBA 10/2021 - 02/2006
11	CytokinesIBA 09/2022 - 06/2010
11	MicroRNAs (MicroRNA)IBA 10/2021 - 07/2012
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2011
9	bazedoxifeneIBA 02/2021 - 01/2016
9	FLLL 32IBA 06/2012 - 03/2010
8	Biological ProductsIBA 02/2018 - 04/2010
7	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 09/2013
7	SurvivinIBA 01/2021 - 04/2010
7	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 02/2009
5	Caspase 3 (Caspase-3)IBA 12/2011 - 03/2009
4	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022 - 03/2014
4	Long Noncoding RNAIBA 01/2021 - 07/2019
4	Raloxifene Hydrochloride (Evista)FDA Link 01/2021 - 01/2017
4	EnzymesIBA 10/2020 - 04/2015
4	Small Interfering RNA (siRNA)IBA 01/2020 - 12/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 03/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Indicators and Reagents (Reagents)IBA 11/2021 - 01/2021
3	ApolipoproteinsIBA 02/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2011
3	Interleukin-11 (Interleukin 11)IBA 01/2021 - 11/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 01/2010
3	Phosphotransferases (Kinase)IBA 01/2019 - 05/2012
3	Aldehyde DehydrogenaseIBA 12/2016 - 12/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 03/2010
3	AgarIBA 09/2013 - 09/2009
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2013 - 12/2011
2	Protein Kinases (Protein Kinase)IBA 09/2022 - 01/2019
2	LipopolysaccharidesIBA 10/2021 - 06/2019
2	Apolipoproteins E (ApoE)IBA 02/2021 - 11/2020
2	Cyclin D1IBA 01/2021 - 07/2011
2	GW 4869IBA 01/2021 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2017
2	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 01/2019
2	Ribosomal DNA (rDNA)IBA 10/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 05/2020 - 11/2019
2	ElastinIBA 01/2020 - 01/2018
2	NF-kappa B (NF-kB)IBA 01/2020 - 05/2009
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 03/2019

Therapy/Procedure

35	Therapeutics 03/2022 - 02/2006
12	Drug Therapy (Chemotherapy) 07/2021 - 05/2009
7	Extracorporeal Membrane Oxygenation 12/2022 - 11/2019
4	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2022 - 09/2016
4	Immunotherapy 03/2022 - 04/2015
3	Punctures 01/2022 - 01/2020
3	Radiotherapy 01/2022 - 12/2019
3	Neoadjuvant Therapy 05/2020 - 01/2019
2	Colectomy 08/2021 - 01/2021
2	Castration 11/2020 - 01/2019
2	Precision Medicine 01/2020 - 06/2015